Form 4 for SCYX SCYNEXIS INC
Accepted 2023-01-03 00:00:00 ET · period of report 2023-01-01 · accession 0001209191-23-000155 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-03 | 2023-01-01 | SCYX | Angulo Gonzalez David | CEO | A - Grant | $0.00 | +110.0K | 185.2K | +146% | $0 |
| D | 2023-01-03 | 2023-01-01 | SCYX | Angulo Gonzalez David | CEO | A - Grant | $0.00 | +165.0K | 165.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-01 | A | A | 110,000 | $0.00 | 185,181 | D | — | — | (F1) Represents restricted stock units that vest one third per year over three years on the anniversary of the date of grant. (F2) Includes 200 shares of common stock acquired under the 2014 Employee Stock Purchase Plan in March 2022 (100 shares) and September 2022 (100 shares). |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-01 | A | A | 165,000 | $0.00 | 165,000 | D | $1.56 · — to 2032-12-31 | 165,000 Common Stock | (F3) 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant. |